Food News and Research

RSS

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

The world must prepare for more major nuclear accidents, U.N. Secretary-General Ban Ki-moon said on Wednesday at a Kiev conference marking the explosion of a reactor at Ukraine's Chernobyl nuclear reactor 25 years ago, the Associated Press reports.

22 Apr 2011

Using dietary supplements may lead to health-risk behaviors

Do you belong to the one-half of the population that frequently uses dietary supplements with the hope that it might be good for you?

22 Apr 2011

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.

22 Apr 2011

Health Partners earns NCQA accreditation for high quality care

Health Partners announced today that it is the first health plan in the nation to receive the new, "Multicultural Health Care Distinction" from the National Committee for Quality Assurance, the nation's most trusted independent source for health care quality accreditation.

22 Apr 2011

DEKRA, Health Canada clear ORTHOCON's new Absorbable Bone Hemostat Matrix

ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.

22 Apr 2011

Marinus initiates ganaxolone Phase 2 trial in posttraumatic stress disorder

Marinus Pharmaceuticals, Inc., the leader in the development of neurosteroids for central nervous system disorders, today announced commencement of a proof-of-concept clinical trial of its lead candidate ganaxolone for the treatment of posttraumatic stress disorder.

22 Apr 2011

USPTO issues patent to Oragenics ProBiora3 for oral care

Florida-based biopharmaceutical company Oragenics, Inc. announced today the issuance of patent number 7931892 from the United States Patent and Trademark office for ProBiora3, a proprietary blend of naturally occurring oral bacteria shown to produce a wide range of oral care benefits.

22 Apr 2011

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.

21 Apr 2011

Toddlers having insecure emotional relationship with mothers at increased risk for obesity

Toddlers who do not have a secure emotional relationship with their parents, and particularly their mothers, could be at increased risk for obesity by age 4 ½, according to new research.

21 Apr 2011

Baxter’s first quarter global sales increase 12% to $3.3 billion

Baxter International Inc. today announced strong financial results for the first quarter of 2011, and raised its outlook for full-year 2011.

From Baxter International Inc. 21 Apr 2011

FDA warns four firms to stop making unproven MRSA prevention claims

The U.S. Food and Drug Administration issued four warning letters to companies that manufacture and market over-the-counter (OTC) drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria (MRSA).

21 Apr 2011

Alexion first quarter non-GAAP net income increases to $56.3 million

Alexion Pharmaceuticals, Inc. today announced financial results for the three months ended March 31, 2011. Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $166.1 million, reflecting steady additions of new patients, compared to $117.6 million for the same period in 2010.

21 Apr 2011

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2011 results.

21 Apr 2011

Humans have three different gut types, finds study

In the future, when you walk into a doctor's surgery or hospital, you could be asked not just about your allergies and blood group, but also about your gut type. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and collaborators in the international MetaHIT consortium, have found that humans have 3 different gut types.

21 Apr 2011

Consumer groups applaud U.S. government call for 'phase down' of dental mercury tooth fillings

An amalgam of consumer groups today applauded a move by the U.S. government to support the 'phase down' of dental mercury tooth fillings.

21 Apr 2011

U.N. agencies begin deploying humanitarian aid in western region of Libya

U.N. agencies have begun providing humanitarian assistance in the western region of Libya for the first time since civil unrest began in February, following an April 17 agreement between the organization and the Libyan government to allow a "humanitarian corridor," Bloomberg reports (Varner, 4/19).

21 Apr 2011